These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9840367)

  • 21. The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects.
    Amsterdam JD; Winokur A; Caroff SN; Conn J
    Am J Psychiatry; 1982 Mar; 139(3):287-91. PubMed ID: 7058940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse T3 levels in affective disorders.
    Kjellman BF; Ljunggren JG; Beck-Friis J; Wetterberg L
    Psychiatry Res; 1983 Sep; 10(1):1-9. PubMed ID: 6417704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous study of 24-hour patterns of melatonin and cortisol secretion in depressed patients.
    Branchey L; Weinberg U; Branchey M; Linkowski P; Mendlewicz J
    Neuropsychobiology; 1982; 8(5):225-32. PubMed ID: 7133371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are there any differences between bipolar and unipolar melancholia?
    Mitchell P; Parker G; Jamieson K; Wilhelm K; Hickie I; Brodaty H; Boyce P; Hadzi-Pavlovic D; Roy K
    J Affect Disord; 1992 Jun; 25(2):97-105. PubMed ID: 1644992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin sensitivity to dim white light in affective disorders.
    Nathan PJ; Burrows GD; Norman TR
    Neuropsychopharmacology; 1999 Sep; 21(3):408-13. PubMed ID: 10457538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The behavioral high-risk paradigm and bipolar affective disorder, VIII: Serum free cortisol in nonpatient cyclothymic subjects selected by the General Behavior Inventory.
    Depue RA; Kleiman RM; Davis P; Hutchinson M; Krauss SP
    Am J Psychiatry; 1985 Feb; 142(2):175-81. PubMed ID: 3970242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian rhythms in melatonin and cortisol secretion in depression.
    Wetterberg L; Beck-Friis J; Kjellman BF; Ljunggren JG
    Adv Biochem Psychopharmacol; 1984; 39():197-205. PubMed ID: 6464829
    [No Abstract]   [Full Text] [Related]  

  • 29. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
    Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
    J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased platelet monoamine oxidase activity in affective disorders.
    Reveley MA; Glover V; Sandler M; Coppen A
    Psychopharmacology (Berl); 1981; 73(3):257-60. PubMed ID: 6787645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical symptoms and platelet monoamine oxidase in subgroups and different states of affective disorders.
    Wahlund B; Sääf J; Wetterberg L
    J Affect Disord; 1995 Oct; 35(1-2):75-87. PubMed ID: 8557890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders.
    Yehuda R; Boisoneau D; Mason JW; Giller EL
    Biol Psychiatry; 1993 Jul 1-15; 34(1-2):18-25. PubMed ID: 8373936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of psychomotor activation in discriminating unipolar from bipolar disorders: a classification-tree analysis.
    Cassano GB; Rucci P; Benvenuti A; Miniati M; Calugi S; Maggi L; Pini S; Kupfer DJ; Maj M; Fagiolini A; Frank E
    J Clin Psychiatry; 2012 Jan; 73(1):22-8. PubMed ID: 22316575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lysine vasopressin in depressed patients on mood and 24-hour rhythm of growth hormone, cortisol, melatonin and prolactin.
    Zohar J; Drummer D; Edelstein ED; Kaiser N; Belmaker RH; Nir I
    Psychoneuroendocrinology; 1985; 10(3):273-9. PubMed ID: 3903821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent structure of unipolar and bipolar mood symptoms.
    Ahmed AO; Green BA; Clark CB; Stahl KC; McFarland ME
    Bipolar Disord; 2011; 13(5-6):522-36. PubMed ID: 22017221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects.
    Rubin RT; Heist EK; McGeoy SS; Hanada K; Lesser IM
    Arch Gen Psychiatry; 1992 Jul; 49(7):558-67. PubMed ID: 1627047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nocturnal melatonin and cortisol secretion in newly admitted psychiatric inpatients. Implications for affective disorders.
    Steiner M; Brown GM; Goldman S
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(1):21-7. PubMed ID: 2147898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressive psychomotor disturbance, cortisol, and dexamethasone.
    Mitchell P; Hadzi-Pavlovic D; Parker G; Hickie I; Wilhelm K; Brodaty H; Boyce P
    Biol Psychiatry; 1996 Nov; 40(10):941-50. PubMed ID: 8915553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychomotor disturbance in depression: defining the constructs.
    Parker G; Hadzi-Pavlovic D; Brodaty H; Boyce P; Mitchell P; Wilhelm K; Hickie I; Eyers K
    J Affect Disord; 1993 Apr; 27(4):255-65. PubMed ID: 8509526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.